Dr. Desai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Levine Cancer Institute 1021 Morehead Medical Drive, Suite A Charlotte, NC 28204 Phone: (980) 442-2000 Fax: (704) 355-5800
1021 Morehead Medical Drive, Suite A
Charlotte, NC 28204Phone+1 980-442-2000Fax+1 704-355-5800- Is this information wrong?
Summary
- Dr. Payal Desai is a hematologist. She is experienced in sickle cell, thrombotic disorders, and classical hematology.
Education & Training
- University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2009 - 2012
- University of Louisville School of MedicineResidency, Internal Medicine, 2006 - 2009
- University of Louisville School of MedicineClass of 2006
Certifications & Licensure
- OH State Medical License 2012 - 2025
- NC State Medical License 2022 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Kidney Function in Sickle Cell Anemia Start of enrollment: 2017 Nov 17
Roles: Sub-Investigator, Contact
- The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia Start of enrollment: 2022 Jul 05
Roles: Contact, Sub-Investigator
- Cognitive Behavioral Therapy and Real-Time Pain Management Intervention for Sickle Cell Via Mobile Applications Start of enrollment: 2020 Aug 12
- Join now to see all
Publications & Presentations
PubMed
- Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.Mark T Gladwin, Victor R Gordeuk, Payal C Desai, Caterina Minniti, Enrico M Novelli, Claudia R Morris, Kenneth I Ataga, Laura De Castro, Susanna A Curtis, Fuad El Rass...> ;The Lancet. Haematology. 2024 Mar 27
- Evaluating self- vs interviewer-administered screening for depression in sickle cell disease.Lysandrou, M., Quaye, N., Landes, K., Crawford, R., Desai, P., Creary, S., Schnell, P., Cronin, R.> ;Blood Advances. 2024 Feb 13
- Efficacy and Safety of Combined Deferiprone and Deferasirox in Iron-Overloaded Patients: A Systematic Review.Ahmed Salem, Payal Desai, Ahmed Elgebaly> ;Cureus. 2023 Nov 1
- Join now to see all
Abstracts/Posters
- The Effects of Utilization of Individualized Pain Plans in Treatment of Vaso-Occlusive Crises in the Emergency DepartmentPayal Desai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Cardiac Injury and Microvascular Ischemia in Sickle Cell DiseasePayal Desai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Effect of Age on Healthcare Utilization in Patients with Sickle CellPayal Desai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Managing Acute and Chronic Pain in Patients With Sickle Cell Disease60th American Society of Hematology Annual Meeting - 12/3/2018
- High-Throughput Mirna Analysis Suggests Pro-Inflammatory Profile in Sickle Cell Disease2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Iron Overload Is Under-Recognized and Under-Treated in SCD: A Report from the GRNDaD Registry2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- Sickle Cell Disease: No Longer the Road Less TravelledDecember 4th, 2018
- Does This Child Have Both Beta and Alpha Thalassemia Trait?June 2nd, 2016
- ‘Digital Deserts’ Send Doctors Out on House Calls to Fight VirusJune 18th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: